Publications
- Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate((R)): Final report from a prospective study2018 | Second Faculty of Medicine
- Quality of life of pediatric patients with haemophilia in the Czech Republic - experiences of one centre2017 | Second Faculty of Medicine
- Successful prophylactic treatment of FEIBA in the prevention of bleeding in patients with severe haemophilia A and high titre of FVIII inhibitor2017 | Second Faculty of Medicine
- Novel approaches to the treatment of hemophilia2016 | Second Faculty of Medicine
- Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children: Results of a phase 3 trial2016 | Second Faculty of Medicine
- FVIII inhibitor development according to concentrate: Data from the EUHASS registry excluding overlap with other studies2016 | Second Faculty of Medicine
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for factor replacement therapy in patients with haemophilia during invasive procedures and surgery2016 | Publication without faculty affiliation
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with congenital haemophilia and inhibitors to FVIII/FIX2016 | Publication without faculty affiliation
- Inhibitors incidence rate in Czech previously untreated patients with haemophilia A has not increased since introduction of recombinant factor VIII treatment in 20032015 | Second Faculty of Medicine
- Inhibitor development in non-severe haemophilia across Europe2015 | Second Faculty of Medicine
Loading network view...